PD 166866 is a potent inhibitor for both ATP competitive pyrido [2,3-d]pyrimidine tyrosine kinase and for FGF-2 (bFGF). It has no effect on c-Src, PDGFR-b, EGFR or insulin receptor tyrosine kinases, or MEK, PKC, or CDK4. PD 166866 is an inhibitor of Flg (FGFR1).
Zhu, X., et al.: Science, 251, 90 (1991), Davies, D.E., et al.: Biochem. Pharmacol., 51, 1101 (1996), Panek, R.L., et al.: J. Pharmacol. Exp. Ther., 286, 569 (1998), Iacoangeli, A., et al.: Biochimie, 82, 35 (2000),
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn